FGF21 and early-onset autosomal dominant Alzheimer disease: We also identified a potential beneficial effect of the major allele at FGF21 rs838133 on cardiovascular outcomes, with the strongest association for venous thromboembolism, as well as on Alzheimer’s disease and lifespan.